Search clinical trials for: GDC-0919
Total 1895 results
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedSolid TumorUnited States, Korea, Republic of, Spain, France
-
Nantes University HospitalRoche Pharma AG; Janssen, LPActive, not recruitingMantle Cell LymphomaFrance, United Kingdom
-
Genentech, Inc.Completed
-
AbbVieAvailableMultiple Myeloma | Non-Hodgkin's Lymphoma | Amyloidosis | Chronic Lymphocytic Leukemia (CLL) | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Plasma Cell Leukemia
-
Fondazione Italiana Linfomi - ETSTerminatedT-Cell Lymphoma Relapsed | T-Cell Lymphoma RefractoryItaly
-
AbbVieRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)Australia, China, New Zealand, Taiwan
-
AbbVieGenentech, Inc.WithdrawnRelapsed/Refractory Non-Hodgkin's Lymphoma
-
AbbVieGenentech, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
Roswell Park Cancer InstituteAbbVieCompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | Metastatic Prostate Carcinoma in the Soft Tissue | Castration Levels of Testosterone | Prostate Carcinoma...United States
-
AbbVieRoche-GenentechCompletedRenal Impairment | Renal DiseaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | Refractory Acute LeukemiaUnited States
-
Radboud University Medical CenterCompletedProstatic Neoplasms | Immunotherapy | Vaccines | Dendritic CellsNetherlands
-
M.D. Anderson Cancer CenterAbbVie; Syndax Pharmaceuticals; Break Through CancerNot yet recruiting
-
AbbVieAstellas Pharma Inc; Genentech, Inc.CompletedAcute Myeloid Leukemia (AML)United States
-
M.D. Anderson Cancer CenterWithdrawnRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
PrECOG, LLC.Genentech, Inc.CompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma Follicular | Non-Hodgkin's Lymphoma, Adult High GradeUnited States
-
Memorial Sloan Kettering Cancer CenterPfizerCompleted
-
Kerry RogersJanssen Research & Development, LLCWithdrawnChronic Lymphocytic Leukemia | Loss of Chromosome 17p
-
AbbVieNo longer availableMyelofibrosis | Lymphoblastic Lymphoma | Acute Lymphocytic Leukemia (ALL)United States
-
AbbVieMerck Sharp & Dohme LLCTerminatedCancer - Acute Myeloid LeukemiaUnited States, Australia, Spain
-
Steven E. CoutreCompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Luke, Jason, MDLumos PharmaWithdrawn
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | 17p Deletion | Cancer of the Blood and Bone MarrowUnited States, Australia, Canada, France, Germany, Poland, United Kingdom
-
Genentech, Inc.AbbVie (prior sponsor, Abbott)CompletedLymphocytic Leukemia, ChronicUnited States, United Kingdom
-
Hoffmann-La RocheCompletedMultiple MyelomaSpain, Denmark, Netherlands, Sweden, Poland, France, Germany, Czechia, Norway
-
AbbVieCompletedLeukemia | Cancer | T-cell Prolymphocytic Leukemia (T-PLL)United States, Australia, Austria, Finland, France, Germany, Italy, Netherlands, United Kingdom
-
Craig Portell, MDAbbVieCompletedLymphoma, Mantle-Cell | Recurrent Lymphoma, Mantle-CellUnited States
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingChronic Lymphocytic Leukemia | Ibrutinib ResistanceUnited States
-
Kerry RogersActive, not recruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
AbbVieF. Hoffmann-La Roche Ltd; German CLL Study Group (GCLLSG); Dana-Farber Cancer...RecruitingChronic Lymphocytic Leukemia (CLL)United States, Australia, Austria, Bulgaria, Germany, Italy, Spain, Israel, Brazil, Romania, United Kingdom
-
Hoffmann-La RocheAbbVie; German CLL Study GroupActive, not recruitingLymphocytic Leukemia, ChronicUnited States, Spain, France, United Kingdom, Australia, Canada, Denmark, Germany, Italy, Brazil, Argentina, Estonia, New Zealand, Austria, Bulgaria, Croatia, Romania, Russian Federation, Poland, Switzerland, Mexico
-
Swiss Group for Clinical Cancer ResearchCompletedFollicular LymphomaSwitzerland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnRefractory Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Genentech, Inc.CompletedHealthy VolunteerUnited States
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
AbbVieActive, not recruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)Japan
-
Jonsson Comprehensive Cancer CenterActive, not recruiting
-
Beth ChristianGenentech, Inc.; CelgeneActive, not recruitingRecurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Burkitt Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma and other conditionsUnited States
-
AbbVieCompletedLymphoblastic Lymphoma | Acute Lymphoblastic Leukemia (ALL)United States, Australia
-
Genentech, Inc.CompletedHealthy VolunteersUnited Kingdom
-
M.D. Anderson Cancer CenterRigel Pharmaceuticals,Inc.Not yet recruitingMutant IDH1 Inhibitor OlutasidenibUnited States
-
Genentech, Inc.Completed
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndrome (MDS)United States, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, Hungary
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
The First Affiliated Hospital of Soochow UniversityRecruitingB Acute Lymphoblastic Leukemia | High Risk Acute Lymphoblastic Leukemia | Ph-Negative ALLChina
-
AbbVieGenentech, Inc.Active, not recruiting
-
Stanford UniversityNational Cancer Institute (NCI); University Hospitals Cleveland Medical CenterCompletedRecurrent Skin Cancer | Basal Cell Carcinoma of the SkinUnited States